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Abstract
Background: Erythropoietin (EPO) and its receptor (EPOR) are expressed in the developing brain and their
transcription is upregulated in adult neurons and glia upon injury or neurodegeneration. We have shown
neuroprotective effects and improved cognition in patients with neuropsychiatric diseases treated with EPO.
However, the critical EPO targets in brain are unknown, and separation of direct and indirect effects has remained
difficult, given the role of EPO in hematopoiesis and brain oxygen supply.
Results: Here we demonstrate that mice with transgenic expression of a constitutively active EPOR isoform (cEPOR)
in pyramidal neurons of cortex and hippocampus exhibit enhancement of spatial learning, cognitive flexibility,
social memory, and attentional capacities, accompanied by increased impulsivity. Superior cognitive performance is
associated with augmented long-term potentiation of cEPOR expressing neurons in hippocampal slices.
Conclusions: Active EPOR stimulates neuronal plasticity independent of any hematopoietic effects and in addition
to its neuroprotective actions. This property of EPOR signaling should be exploited for defining novel strategies to
therapeutically enhance cognitive performance in disease conditions.
Background
The hematopoietic growth factor erythropoietin (EPO)
increases erythrocyte numbers by preventing apoptosis of
erythroblasts in the bone marrow. Recombinant human
EPO (rhEPO) is a clinically widely used drug, approved
for the treatment of anemia worldwide. The surprising
clinical observation that rhEPO improves cognitive func-
tion has always been attributed to the increase in hemo-
globin levels and thus enhanced tissue oxygenation (for
review see [1-3]). Even after the discovery of EPO and
EPO receptor (EPOR) in the brain [4,5], it took years
until direct EPO effects on the central nervous system
were first explored by in vivo experiments [6]. In the fol-
lowing, EPO turned out to have potent antiapoptotic,
antioxidative and anti-inflammatory properties in the
brain (for review see for example [7,8]). Downstream sig-
naling pathways of EPO in cells of the nervous system
were extensively explored, showing an involvement of
signal transducers and activators of transcription
(STATs), phosphatidylinositol-3 kinase (PI3K)/AKT,
RAS/extra-cellular signal-regulated kinase (ERK1/2),
nuclear factor kappa B (NF-kappa B) and calcium [9-11].
A large number of preclinical studies followed, devoted
to the employment of EPO as a neuroprotective agent
(for review see [12]). Recent clinical trials on patients
with schizophrenia [13,14] or chronic progressive multi-
ple sclerosis [15] as well as a trial involving extremely
preterm infants [16], which all demonstrated improved
cognitive outcome upon EPO treatment, strongly sug-
gested that this growth factor should be considered as a
candidate neuroprotective drug counteracting cognitive
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any medium, provided the original work is properly cited.decline. Nevertheless, the relevant mechanisms of action
remained unclear and difficult to formally separate from
blood oxygenation effects.
As compared to neuroprotection studies in disease
models (for review see [12]), work on the function of the
EPO system in normal brain is scarce. Based on the pro-
minent effects of EPO on cognition, we hypothesized
that an important physiological role of EPO in postnatal
life or adulthood might be the modulation of neuroplasti-
city and of higher cognitive functions. We showed pre-
viously that in healthy young mice high-dose EPO
treatment over three weeks enhanced hippocampal long-
term potentiation (LTP) and memory [17], as well as
executive and attentional functions [18]. A recent func-
tional magnetic resonance imaging (fMRI) study on
healthy volunteers reported enhancement of the hippo-
campal response during memory retrieval after only one
high dose of EPO [19]. In all of these cases, EPO was
applied peripherally, penetrated an intact blood-brain-
barrier [20-22], and likely bound to all major classes of
brain cells expressing EPOR, making it impossible to
delineate the cell type(s) responsible for enhanced
cognition.
To explore whether active EPOR in cortical neurons has
a direct impact on cognitive functions in the non-injured
brain, we chose a transgenic strategy. To be independent
of rhEPO and to genetically define the neuronal target
cells, we expressed a constitutively active form, EPOR
R129C
in the postnatal mouse forebrain, using a transgene driven
by the a-calcium/calmodulin-dependent protein kinase II
(a-CaMKII) promoter. The substitution in EPOR
R129C
(cEPOR) confers growth factor-independent survival and
tumorigenicity to hematopoietic Ba/F3 cells that are nor-
mally dependent on interleukin-3 for growth and survival
[23,24]. The constitutive activity results from the forma-
tion of a disulfide-linked receptor homodimer, mimicking
the EPO-bound form [25]. Expression of cEPOR thus acti-
vates EPOR signaling without requirement of a ligand [26].
We show here that cEPOR expression in pyramidal
neurons of cortex and hippocampus of transgenic (TG)
mice prominently enhances higher cognitive perfor-
mance. Superior cognition is correlated with enhanced
paired-pulse facilitation and long-term potentiation at
the Schaffer collateral CA1 synapse, indicative of
increased short- and long-term plasticity. Cognitive aug-
m e n t a t i o ni nt h i sg e n e t i cm o d e li sd i f f e r e n tf r o mt h a t
observed in mice receiving rhEPO injections and comes
at the price of higher impulsivity and reduced behavioral
control under strong cognitive challenge. We conclude
that active EPOR stimulates neuronal plasticity indepen-
dent of any hematopoietic effects and in addition to its
neuroprotective properties.
Results
Transgenic cEPOR expression in cortical and hippocampal
neurons
To systematically investigate the role of the EPO sys-
tem in learning, memory and attention, we generated a
TG mouse line expressing a constitutively active form
of EPOR (cEPOR) under control of the a-CaMKII pro-
moter (Figure 1A), which restricts expression of
cEPOR to forebrain pyramidal neurons of postnatal
mice. A hemagglutinin (HA) tag at the amino terminus
of cEPOR allowed monitoring of transgene expression.
Of three independent lines produced, we analyzed two
(TG1 and TG2) in detail, which showed a similar spa-
tio-temporal expression pattern of the mutant receptor
(Figure 1B and Additional file 1). In fact, cEPOR
expression was enriched in cortex and hippocampus
(Figure 1B, C) but not in cerebellum and peripheral
tissues (Figure 1C). Western blot analysis demon-
strated the presence of a 64 kDa mutant receptor in
the brains of TG animals that was regulated develop-
mentally over time and augmented in early postnatal
days (Figure 1D). Mice lacked any signs of neuro-
pathology, were long-lived, and reproduced well.
Animals in both lines showed normal growth and
development, body weight, mating behavior and gross
brain morphology, virtually identical to that of WT
mice (see Additional file 2). Moreover, hematocrit
levels were comparable between WT and TG mice
(WT mice: 45.00 ± 0.3162%, N = 5; TG mice: 46.00 ±
1.080%, P = 0.36; N = 4). Thus, behavioral differences
would not be secondary to developmental changes of
the brain or hyperoxygenation.
Slight hyperactivity but normal basic behavior of cEPOR
TG mice
We first assessed basic behavioral functions, such as
locomotor and exploratory activity, anxiety, and motor
performance, in cEPOR TG mice in comparison to WT
littermates. In the elevated plus maze, there was the
expected significant effect of arms (2-way ANOVA, F
(2,90) = 66.70; P < 0.0001), but neither a genotype (P =
0.9997) nor an interaction effect (P = 0.4748), indicating
comparable anxiety levels between TG and WT mice
(Figure 2A). In the open field test, mice did not differ
with respect to the time spent in zones (2-way ANOVA,
effect of genotype P = 0.9996) (Figure 2B). However, TG
mice showed increased velocity (Mann-Whitney U-test,
P = 0.003) (Figure 2B inset) as well as distance travelled
(data not shown). There were no differences between
groups in exploratory activity, locomotor coordination,
motor learning and acoustic startle response (Figure 2C,
D,E).
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Page 2 of 16Figure 1 Construction and characterization of HA-cEPOR TG mice (’TG1’). (A) Construct HA-cEPOR used for production of HA-cEPOR TG
mice. HA-cEPOR, flanked by a hybrid intron at the 5’ end and a polyadenylation signal at the 3’ end was placed under the control of the a-
CaMKII promoter. (B) Forebrain-specific expression of HA-cEPOR transgene revealed by immunohistochemistry. A monoclonal antibody against
the HA-tag was used to stain coronal sections of the hippocampus. Expectedly, HA-cEPOR expression is absent in WT mice [(a) and (b) are
magnifications of the respective regions of interest]. In TG mice, HA-cEPOR expression is restricted to pyramidal neurons of the cortex (c), CA1
(d) as well as CA3 subregions of the hippocampus and granular layer of the dentate gyrus. Scale bars; 100 μm and 500 μm. (C) Tissue-specific
expression of HA-cEPOR mRNA (top) and protein (bottom) in TG mice. TG mRNA expression was detected by PCR using TG specific primers,
yielding a 362 bp product. Western blot analysis of HA-cEPOR using a monoclonal antibody against HA-tag revealed a 64 kDa band. HA-cEPOR
mRNA and protein were expressed in cortex (CX) and hippocampus (HP) of TG mice but not in cerebellum (CB) or in peripheral tissues (LIV: liver;
KID: kidney). GAPDH was used as the internal control for both mRNA (431 bp) and protein (36 kDa) expression analysis. (D) Developmental
regulation of the HA-cEPOR transgene. HA-cEPOR transgenic mRNA and protein expression was not seen in fetal tissue (’embryonic’ day 12 and
17), but detected at early postnatal days (P0, P14) and remained constant until adulthood.
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Page 3 of 16Enhanced spatial learning and cognitive flexibility
Morris water maze, a sensitive test for hippocampus-
dependent learning/memory processes [27], yielded
comparable performance of TG and WT in the visible
platform task (data not shown). In contrast, in the hid-
den platform task, a significant effect of days (2-way
ANOVA for repeated measures F(7,203) = 24.66; P <
0.0001) as well as a significant effect of genotype (2-way
ANOVA for repeated measures, F(1,29) = 8.863; P =
0.006) and no interaction effect (P =0 . 8 7 )w e r e
observed (Figure 2F). The tendency of a different start-
ing point on day one of the hidden platform task made
us analyze the four trials of this day separately. The pat-
tern obtained explains the tendency, even though 2-way
ANOVA for repeated measures failed to yield a signifi-
c a n tg e n o t y p ee f f e c to ft h ew i t h i n - d a yc u r v e( P = 0.09;
inset Figure 2F). This pattern of faster within-day learn-
ing is lost with increased overall level of performance
(see Additional file 3). To exclude hyperactivity as a
potential confounding variable, we evaluated the dis-
tance travelled for locating the hidden platform, a para-
meter independent of swimming speed. Again, there was
a significant effect of genotype (2-way ANOVA for
repeated measures, F(1,29) = 6.791; P = 0.014; Figure
2G), indicating enhanced hippocampus-dependent
learning and memory function in cEPOR TG mice. The
similar performance level of both groups on day eight of
the hidden platform paradigm (P = 0.8) may explain the
negative result in the probe trial (inset Figure 2F) and
allowed us to further assess cognitive flexibility of
cEPOR TG mice using the reversal paradigm. Again, 2-
way ANOVA for repeated measures revealed a signifi-
cant effect of days (F(7,196) = 55.71, P < 0.0001), signifi-
cant effect of genotype (F(1,28) = 5.090, P = 0.03) and a
significant interaction effect (F(7,196) = 3.649, P =
0.001). Post-hoc analysis indicated a significant differ-
ence on day one (Bonferroni post-hoc test, P < 0.0001).
To further delineate performance of both groups on this
c r i t i c a ld a yo n e ,w ea p p l i e da2 - w a yA N O V Af o r
repeated measures over the four trials of this day. Both
groups significantly improved over time (F(3,84) =
12.71, P < 0.0001). However, there was a significant gen-
otype effect (F(1,28) = 9.632, P = 0.004), pointing to fas-
ter adaptation of cEPOR TG mice to the new platform
position (Figure 2H and inset).
Enhanced synaptic plasticity of the hippocampus
We hypothesized that the improvements of hippocampal
learning are associated with a higher degree of synaptic
plasticity. To assess changes in synaptic function and
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Figure 2 Essentially normal basic behavior of cEPOR TG mice contrasts the distinctly superior cognitive performance.T Gm i c ew e r e
normal in basic behavioral functions (A - E) except for slight hyperactivity, as demonstrated by increased velocity in the open field (inset B).I n
basic cognitive tasks, that is spatial learning/memory and cognitive flexibility as evaluated by Morris water maze (F - H) and social memory (I),
cEPOR TG mice were significantly superior to WT. WT n = 18; TG n = 13; mean ± SEM presented. Insets in F: within - day learning on day one
of the hidden platform task: all four trials presented; probe trial expressed as % of time spent in target quadrant; Inset in H: within-day learning
on day one of the reversal task: all four trials presented.
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Page 4 of 16plasticity at the Schaffer collateral-CA1 synapse, extra-
cellular field potential recordings were performed in
stratum radiatum of the CA1 subfield of acute hippo-
campal tissue slices. Basal synaptic function and neuro-
nal excitability were judged on the basis of input-output
curves and synaptic plasticity was tested by paired-pulse
stimulation and long-term potentiation (LTP)-inducing
trains of tetanic stimuli. The absolute amplitudes and
slopes of orthodromically evoked field excitatory postsy-
naptic potentials (fEPSPs) did not differ significantly
among WT and TG mice. However, the normalized
input-output curves (10-150 μA stimuli) were slightly
right-shifted for cEPOR mice at low stimulation intensi-
ties (≤70 μA, Figure 3A,B). On average, half maximum
response amplitudes were obtained with 30 μAa n d
50 μA stimuli in WT (n = 14 slices) and TG mice (n =
12 slices), respectively.
Clear differences were observed in response to twin-
pulse stimulation. In cEPOR TG mice, paired-pulse
facilitation with interpulse durations of up to 150 ms
was significantly increased as compared to WT mice
(Figure 3C,D). At the shortest interpulse interval tested
(25 ms), the fEPSP amplitudes increased by 59.3 ±
15.5% and 127.9 ± 22.7% for WT (n = 12 slices) and TG
mice (n = 11), respectively, and fEPSP slopes increased
by 113.6 ± 20.2% and 268.2 ± 45.4%.
LTP-inducing stimuli (three trains of 100 Hz, each
lasting for one second) also resulted in a more pro-
nounced potentiation of fEPSPs in cEPOR mice. This
augmentation was already evident during the initial
phase of LTP right after high frequency stimulation and
remained stable for the following 60 minutes analyzed,
that is the phase considered as early LTP (Figure 3E,F).
Immediately after tetanic stimulation, that is the phase
being referred to as post-tetanic potentiation (PTP),
fEPSP amplitudes were increased by 68.6 ± 9.4% and
190.5 ± 22.4% for WT and TG mice, respectively, and
fEPSP slopes increased by 133.3 ± 16.0% and 283.3 ±
47.9% (Figure 3F). This initial post-tetanic potentiation
decayed over the course of three to five minutes and the
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Figure 3 cEPOR mice reveal improved synaptic short- and long-term plasticity. (A,B) Input-output curves of evoked EPSPs: The moderate
right-shift of response amplitudes (A) and slopes (B) in cEPOR mice suggests slightly reduced basal excitability (WT n = 10, TG n = 10). (C,D)
Short-term plasticity as tested by paired-pulse facilitation was markedly enhanced in cEPOR mice. The amplitude (C) and slope (D) of the second
EPSP are normalized to the first EPSP of a given twin pulse. Plotted are the averages of 12 (wildtype) and 11 (cEPOR TG) slices. Error bars
represent SEM and the level of significance of the changes observed is indicated. The sample responses shown in the inset (D) were elicited by
30 μA stimuli separated by 25 ms; stimulation artefacts are truncated. Baseline stimulation intensities (adjusted to obtain about half maximum
fEPSP amplitudes) for stimulation in PPF and long-term potentiation (LTP) experiments differed only slightly among genotypes. On average, the
chosen stimulation intensities were 50 μA for WT and 60 μA for transgenic slices. (E,F) Also, post tetanic potentiation (PTP) as well as LTP was
more pronounced in cEPOR mice. LTP was induced at time 0; plotted are the normalized averages of 11 slices for each genotype. The sample
responses in the inset (F) show EPSPs under baseline conditions, immediately after the LTP-inducing stimulus, that is the phase of PTP, and 60
minutes after stimulation. Responses were elicited by 60 μA stimuli, scaling is identical to panel D.
Sargin et al. BMC Biology 2011, 9:27
http://www.biomedcentral.com/1741-7007/9/27
Page 5 of 16evoked responses stabilized. One hour after LTP induc-
tion, fEPSP amplitudes were still increased by 38.4 ±
7.4% and 116.7 ± 18.7% and fEPSP slopes were elevated
by 51.0 ± 13.2% and 140.7 ± 32.5% (Figure 3F).
Social memory, attention and higher cognitive capacities
Would EPO-EPOR signaling also affect higher cortical
functions that cannot be easily correlated with electro-
physiological readouts? We first addressed social func-
tions in cEPOR TG mice.W h i l et h e r ew e r en o
differences in social interaction and social approach (data
not shown), cEPOR TG mice showed enhanced social
memory (P = 0.04, Figure 2I). This behavior was not due
to increased exploratory activity, since performance in
the hole board test did not differ between groups (Figure
2C). Additionally, no differences in olfaction were
detected between groups (data not shown) indicating
that this finding reflects improved memory function in
the area of social interaction.
We next assessed attention and behavioral control in
these mice using the 5-choice serial reaction time task
(5-CSRTT) (Figure 4A and Additional file 4) In this test,
mice are trained on an everyday basis over many
months to adequately respond to a short (≤1.4 second)
light stimulus. Light stimuli appear pseudorandomly in
one of five equally distant stimulus holes. Mice are only
rewarded if they make a nose poke in the location
where the light shows up. To be considered correct,
responses have to occur in a short limited-time window
after stimulus presentation. After reaching stable perfor-
mance, this trained behavior is challenged via different
interfering manipulations (for example sound distracters,
changing stimulus durations and so on).
Training under baseline conditions for 21 days revealed
enhanced attentional abilities in cEPOR mice demon-
strated by significantly lower reaction times (2-way
ANOVA for repeated measures, effect of genotype F
(1,16) = 10.73, P = 0.005, Figure 4B). Post-hoc analysis
indicated a significant difference in the first trial block
(that is the first ten trials collapsed over 21 days) (P <
0.001). This pattern remained robust even in face of
higher cognitive challenges in intervention phase 2
(INT2) (effect of genotype F(1,14) = 10.42, P = 0.006;
effect of inter-trial interval (ITI) F(3,42) = 19.83, P <
0.0001; effect of interaction F(3,42) = 5.455), P = 0.003,
Figure 4C). Post-hoc evaluation revealed significantly
lower reaction times in cEPOR TG mice in ITI5 and ITI6
(P < 0.001 and P < 0.05, respectively). Furthermore,
cEPOR TG mice tended to show less premature
responses in INT2 compared to WT littermates (effect of
genotype F(1,14) = 6.658, P = 0.022, Figure 4D). Since
progression until ‘Recovery4’ is performance-dependent,
unifying various aspects of learning and cognitive control,
we analyzed the proportion of mice finishing this phase
until experimental day 250. Survival analysis showed a
significant difference between groups (P = 0.03), indicat-
ing overall faster task progression in cEPOR TG mice
(Figure 4E).
Resistance to behavioral distracters
Having obtained a consistently superior performance of
TG mice in the whole series of consecutive 5-CSRTT
attentional challenges, we exposed the mice to interfer-
ing acoustic stimuli. In the intervention phase 5 (INT5),
mice were randomly confronted either with trials, where
a sound distracter was simultaneously applied with a
short light stimulus, or with trials lacking such distract-
ing auditory stimulus. The effect of the sound distracter
on attentional accuracy was investigated. In cEPOR TG
mice, the sound distracter did not affect attentional
accuracy (Wilcoxon Test, P =0 . 9 4 )i nc o n t r a s tt oW T
littermates where sound distraction led to a decrease in
accuracy (P = 0.01, Figure 4F). Reaction times showed
here only borderline significance (effect of genotype P =
0.057). Sound distraction led to a similar increase in
reaction times in both groups (effect of sound F(1,14) =
6.572, P = 0.023, Figure 4G).
Increased impulsivity and reduced behavioral control
under challenge
Experimental cEPOR transgene expression was not ubi-
quitous in all EPO responsive cells in the brain, but
restricted to forebrain pyramidal neurons, suggesting
that a natural balance of stimulatory and inhibitory cir-
cuits may have been perturbed. We therefore wondered
whether overall superior cognitive performance would
come at a ‘price’ a n ds e a r c h e df o rs u b t l eb e h a v i o r a l
defects. Indeed, an interesting behavioral abnormality
was impulsivity. Under conditions of long inter-trial
intervals (11 seconds) in combination with variable,
short stimulus duration, cEPOR TG mice tended to
have more omissions compared to WT littermates
(Mann-Whitney U-test, P = 0.02, Figure 5A). In contrast
to their resistance towards attentional distractions,
cEPOR TG mice had more premature responses in the
task where they were confronted with sound distracters,
that is responses that occurred before the light-coupled
sound appeared (Mann-Whitney U-test, P = 0.038, Fig-
ure 5B). To address whether signs of increased impulsiv-
ity are also detectable in simpler readouts of this
behavioral feature, we performed the marble burying
test. Indeed, cEPOR TG mice buried more marbles
compared to WT littermates (Mann-Whitney U-test, P
=0 . 0 4 6 ,F i g u r e5 C ) .T h u s ,confining enhanced EPOR
activity to glutamatergic cortical projection neurons in
the reported experiment may have specific disadvan-
tages, and it will be interesting to compare the here
obtained behavioral pattern with the in vivo effects of
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Page 6 of 16enhanced EPO-EPOR signaling in other neuronal
subpopulations.
Discussion
In order to investigate how the EPO system influences
cognitive performance and synaptic plasticity, and to
experimentally prove that previously reported effects of
rhEPO on cognition in patients are independent of EPO
effects on hematopoiesis/brain oxygen supply, we created
a novel mouse model with constitutive EPOR expression
in cortical and hippocampal neurons that are defined by
a-CaMKII promoter activity. This way, we were able to
specifically mimic EPO system function independent of
any ligand in pyramidal neurons of cortex and hippocam-
pus, that is regions pivotal for learning and memory
processes. In other words, we ‘over-accentuated’ the
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Figure 4 cEPOR TG mice perform better in the attentional interventions of the 5-choice serial reaction time task (5-CSRTT). (A)
Experimental design depicting the standard baseline training steps in 5-CSRTT as well as attentional manipulations. (B,C) cEPOR TG mice
showed better attentional performance reflected by shorter reaction times. (D) They displayed less premature responses under lower cognitive
demands and (E) were overall faster in progressing through the consecutive training steps. (F,G) Additionally, they were less distractible and
more resistant towards irrelevant competing auditory stimuli. WT n = 9 to 11; TG n = 7; mean ± SEM presented; INT = intervention; ITI = inter-
trial interval.
Sargin et al. BMC Biology 2011, 9:27
http://www.biomedcentral.com/1741-7007/9/27
Page 7 of 16endogenous action of the EPO system in specific cortical
and hippocampal layers, particularly the CA1 subregion
[28], to delineate the contribution of these neuronal sub-
populations to the EPO effects on cognition. We found
that selective constitutive expression of EPOR in forebrain
neurons leads to a phenotype with superior performance
in higher cognitive tasks. Behaviorally, this phenotype is
accompanied by slightly increased activity and impulsivity.
Electrophysiologically, both short- and long-term plasticity
at the Schaffer collateral CA1 synapses are significantly
increased in cEPOR expressing TG mice.
Field potential recordings revealed augmented paired-
pulse facilitation, short-term potentiation and LTP in
cEPOR TG mice. One possible cause for the differences
observed in the twin-pulse stimulation results might be
the slight right shift of the input-output curves which
suggests somewhat reduced baseline excitability and
thus leaves more room for potentiated response. Even
though the detailed underlying molecular mechanisms
cannot be determined on the basis of our extracellular
recordings, the enhanced paired-pulse facilitation con-
firms that an increased number of transmitter quanta
can be released in cEPOR TG mice (for review see [29]).
Accordingly, the dynamic range of synaptic plasticity
(and hence efficacy) is clearly extended as compared to
WT mice.
The gain in paired-pulse facilitation is comparable to
changes observed earlier in mice receiving EPO injections
[17]. However, in cEPOR TG mice, LTP stabilized at
higher levels. Since both paired-pulse facilitation and LTP
are augmented, both pre- and postsynaptic mechanisms
seem to contribute to the improved synaptic plasticity.
Upon high frequency stimulation (LTP induction), the
immediate phase of post tetanic potentiation is known to
be independent of kinase activity [30]. The following 60
minutes of LTP reflect ‘early LTP’, which at the Schaffer
collateral CA1 synapse is NMDA receptor dependent,
involves activation of various kinases leading to AMPA
receptor phosphorylation, but is independent of protein
synthesis and/or gene transcription [30,31]. Interestingly,
some of the kinases involved in the phosphorylation events
during early LTP (MAPK, PI3K and ERK) are indeed part
of the EPO signaling cascades [10] and thus might consti-
tute putative sites of signal convergence. Nevertheless, the
enhanced spatial learning and cognitive flexibility observed
in cEPOR TG mice suggest that, even though not evalu-
ated electrophysiologically, the late phase of LTP, that is
the phase requiring gene transcription and protein synth-
esis, is augmented as well [30,31].
A detailed and comprehensive behavioral-cognitive
analysis of cEPOR TG mice was performed to demon-
strate that increased EPO signaling in cortex and hippo-
campus enhances a whole array of learning and memory
processes, as well as cognitive flexibility and attentional
capacities, reflected by shorter reaction times and
reduced distractibility through competing irrelevant audi-
tory stimuli. Very similar higher cognitive tasks were
found improved in human patients upon several months
of weekly high-dose intravenous EPO treatment [13-15],
pointing to specific targets of EPO action on cognition
that are common to both mice and humans. Augmented
EPOR signaling in cEPOR TG mice also improved social
memory, which is partly dependent on hippocampal
functions [32]. We note that a recent study reported on
better facial recognition performance in patients with
major depression following high-dose EPO application
[33], supporting social cognition as another selective tar-
get of EPO effects across species.
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Figure 5 cEPOR TG mice show increased impulsivity and reduced behavioral control under conditions of high cognitive challenge. (A)
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Page 8 of 16It is important to point out that there are clear differ-
ences between EPO effects on higher cognition upon
systemic administration to healthy mice [18] as com-
pared to the selective and specific stimulation of the
EPO system in forebrain pyramidal neurons reported
here. In contrast to mice receiving intraperitoneal EPO
injections [18], the cEPOR TG mice did not show
improved performance in the (still relatively basic) initial
5-CSRTT training phases. Their superiority, however,
was pronounced in the highest cognitive challenge tasks,
demanding tremendous attentional capacities.
Surprisingly, under cognitively most challenging condi-
tions, cEPOR TG mice demonstrated more premature
responses as readout of impaired behavioral impulse con-
trol [34]. The slightly hyperactive and impulsive phenotype
of cEPOR TG mice was further confirmed by a simple
additional assay - the marble burying test. Behavioral con-
sequences of this kind were not noted upon high-dose
EPO treatment where the cellular target is defined by the
almost ubiquitous presence of EPOR throughout the
brain. A potential explanation for the cEPOR TG pheno-
type of impulsivity and hyperactivity might be the continu-
ous stimulation of the EPO system exclusively in cortical
projection neurons. Since the frontal cortex has reciprocal
projections to subcortical and basal brain regions [for
example [35-37]], responsible for locomotion, motivation
and impulsivity (for review see for example [38-40]), the
excitation of frontal pyramidal neurons might lead to a
relative deficit in the simultaneous inhibitory regulation of
these areas, consistent with a disturbance of the homeo-
static balance within neuronal networks, resulting in
impulsivity and hyperactivity of TG mice. This hypothesis
is presently under systematic investigation in our labora-
tory through selected cEPOR expression in subpopulations
of inhibitory interneurons.
Interestingly, there is an ongoing debate regarding the
nature of brain EPOR. The fact that non-hematopoietic
but neuroprotective EPO variants have been identified
makes the additional existence of a different EPOR in
the brain very likely (for review see [7,8]). Indeed, the
work of Xiong and others [41,42] may well be inter-
preted along these lines. These authors demonstrated in
a traumatic brain injury model worse outcome of neural
EPOR-deficient mice, but, surprisingly, beneficial effects
of EPO treatment even in the absence of the ‘classical’
neural EPOR. Moreover, they found that EPOR null
mice per se are not impaired in spatial learning, indicat-
ing that the ‘classical’ brain EPOR may not be crucial
for this task. This again emphasizes that the superior
performance of cEPOR TG mice in spatial learning and
memory, induced by over-activation of one selected
population of neurons only, is partly explained by the
provoked dysbalance in neuronal networks. In fact,
some of the cognitive phenotypes observed here may
also be derived from over-activation of downstream sig-
naling cascades in neurons which are not endogenously
triggered by EPO, thereby creating a somewhat ‘artificial’
scenario. Nevertheless, the cEPOR approach taken here
may ultimately help to delineate the role of discrete
neuronal subpopulations in cognitive processes.
EPO and EPOR are expressed at very high levels in
the developing central nervous system [43-47]. In con-
trast, their expression is markedly reduced postnatally
and remains low in the normal adult brain [48]. Both
genes are upregulated under disease conditions in var-
ious different cell types in the brain, possibly to exert
neuroprotective effects [49,50]. Our present data indi-
cate that activated EPOR serves a role in neuroplasticity,
independent of and in addition to its anti-apoptotic neu-
roprotective tasks. Since the steady-state level of both
receptor and ligand is nevertheless low in the uninjured
brain, we suggest that this function may also be disease-
relevant. We propose a model in which EPO-EPOR
induction under disease conditions not only prevents
neuronal cell death, but also triggers the enhanced neu-
ronal plasticity that is required to functionally compen-
sate for lost neuronal functions. It is intriguing that this
could indicate a strategy of the neocortex, which is
known to provide striking functional compensations
after injury.
Conclusions
This study, together with our previous work, strongly
supports a biological role for EPO in cognitive processes.
The potential of this role should be exploited to define
novel strategies to therapeutically enhance brain plasti-
city and cognitive performance in disease conditions.
Methods
Generation and characterization of transgenic (TG) mice
EPOR
R129C (cEPOR) bears a single point mutation at
nucleotide 484, that is in the exoplasmic domain, caus-
ing a substitution of cysteine for arginine at codon 129
of the N terminus (R129C). The cDNA sequence of
cEPOR, containing a hemagglutinin (HA; YPYDVPDY)
tag inserted five residues downstream of the signal pep-
tidase cleavage site [51], was excised with PacI and SalI
from the pMX-HA-cEPOR plasmid. The HA-cEPOR
cDNA was inserted into pNN265 plasmid, with a modi-
fied multiple cloning site, that carries a 5’ hybrid intron
and a 3’ intron plus poly-A signal from SV40 through
PacI and SalI sites. Finally, the entire DNA fragment of
HA-cEPOR, flanked by a hybrid intron at the 5’ end and
a polyadenylation signal from SV40 at the 3’ end was
cut out from pNN265 vector using NotI and placed
downstream of the 8.5 kb a-CaMKII promoter.
The TG founders were produced by pronuclear injec-
tion of the linearized DNA into C57BL6/N (’TG1’) or
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was performed after four to seven backcrosses with
C57BL6/N wildtype mice (that is all results reported in
this study were obtained from generations four to seven
of the TG1 line). The TG1 line was used (because of its
clean C57BL6/N background) for the behavioral experi-
ments presented here. The analysis of line TG2 mice
was performed after eight to nine backcrossings to
C57BL6/N mice.
The genotype of transgenic offspring was analyzed by
PCR of tail genomic DNA using primers specific for the 3’
end of the a-CaMKII promoter sequence (5’-GGGAGGT
AGGAAGAGCGATG-3’)a n dt h e5 ’ end of the HA-
cEPOR cDNA sequence (5’-CACCCTGAGTTTGTC-
CATCC-3’) yielding a 769 bp product. PCR amplification
of the tail DNA was carried out with the following condi-
tions: 2 minutes, 94°C (1 cycle); 30 seconds 94°C, 30 sec-
onds 60°C, 1 minute 72°C (35 cycles), followed by final
extension at 72°C for 10 minutes.
Immunofluorescence
Wildtype and TG male HA-cEPOR mice were transcar-
dially perfused under deep anesthesia with saline fol-
lowed by 4% paraformaldehyde in 0.1 M sodium
phosphate buffer (PBS) (pH 7.4). Brains were removed
from the skulls, postfixed in 4% PFA overnight at 4°C
and subsequently cryoprotected in 30% sucrose/PBS
solution. After being frozen on dry ice, coronal cryosec-
tions (30 μm) were collected, washed briefly with PBS
and incubated for 40 minutes at room temperature (RT)
with 0.1% glycine (Merck, Darmstadt, Germany), 0.1%
Triton X-100 in PBS. Sections were then immersed for
one hour at RT in blocking solution [5% normal horse
serum (NHS), 0.1% Triton X-100 in PBS] and incubated
with mouse monoclonal anti-HA (1:500, Covance, Hiss
Diagnostics, Freiburg, Germany) diluted in 3% NHS,
0.1% Triton X-100/PBS overnight at 4°C. After washing
with PBS, sections were treated with anti-mouse Cy3-
coupled secondary antibody (1:1000, Jackson ImmunoR-
esearch Laboratories-Dianova, Hamburg, Germany) for
one hour at RT. Following PBS washes, sections were
mounted on Super Frost microscopic slides, air dried
and coverslipped using Aqua-Poly/Mount (Polysciences,
Eppelheim, Germany). Sections were imaged with a
fluorescence stereomicroscope (Leica MZ16 FA, Wet-
zlar, Germany).
Protein extraction and immunoblotting
Wildtype and TG HA-cEPOR male mice were sacrificed
by cervical dislocation. The tissue samples were dissected
and immediately frozen on dry ice. For immunoblotting,
tissue samples including hippocampus, cortex, cerebel-
lum, liver and kidney, were homogenized in lysis buffer
(50 mM Tris HCL (pH 8.3), 150 mM NaCl, 40 mM NaF,
5m ME D T A ,5m ME G T A ,1m MN a 3VO4,1 %I g e p a l ,
0.1% Natriumdesoxycholat, 0.1% SDS] containing 1 mM
phenylmethysulfonylfluoride, 10 μg/ml aprotinin and 0.1
mg/ml leupeptin) using an Ultra-turrax homogenizer
(Kinematica, Luzern, Switzerland). The lysates were cen-
trifuged (1200 rpm) for 45 minutes at 4°C. The superna-
tant was collected and mixed with three volumes of
Laemmli buffer [250 mM Tris HCL (pH 8.3), 8% SDS,
40% glycerol, 20% 2-mercaptoethanol, 0.04% pyronin Y],
and boiled for ten minutes at 70°C for immunoblotting.
The protein samples were run on NuPAGE 4 - 12% Bis-
Tris Gel (Invitrogen, Karlsruhe, Germany) for one hour
at 200 V and transferred to a nitrocellulose membrane.
After blocking with 5% milk in Tween 20-Tris-buffered
saline (TTBS) for one hour at RT, membranes were incu-
bated in primary antibodies for rat monoclonal anti-HA
(1:500, Roche, Mannheim, Germany) with mouse mono-
clonal anti-GAPDH (1:10000, Assay Designs/Stressgen,
Ann Arbor, MI, USA) as an internal control. Immunor-
eactive bands were visualized using secondary antibodies
coupled to horseradish peroxidase by enhanced chemolu-
minescence (Amersham, Freiburg, Germany).
RNA isolation and expression analysis by reverse
transcriptase PCR (RT-PCR)
Brains of E12, E17, P0, P14 and adult (two months old)
TG male HA-cEPOR mice were rapidly frozen after
being sacrificed. Tissue was homogenized in Trizol using
an Ultra-turrax homogenizer (Kinematica, Luzern, Swit-
zerland). Total RNA was isolated by using the RNeasy-
Plus kit (Qiagen, Hilden, Germany). During RNA
isolation, on-column DNase digestion was performed
with the RNase-free DNase set (Qiagen, Hilden, Ger-
many). cDNA was prepared using N9 random and Oligo
(dT)18 primers. HA-cEPOR expression was detected by
PCR using the sense (5’ CTACCCATACGACGTCCCAG
3’) and antisense (5’ GCGTCCAGGAGCACTACTTC 3’)
primers specific for the transgene, yielding a 362 bp pro-
duct. GAPDH cDNA was amplified as internal control
using the sense 5’ TGCCAAGGCTGTGGGCAAGG 3’
and antisense 5’ TGTTGGGGGCCGAGTTGGGA 3’ pri-
mers (431 bp). PCR amplification was done under the
following conditions: 2 minutes, 94°C (1 cycle); 45 sec-
onds 94°C, 45 seconds 58°C, 1 minute 72°C (30 cycles),
followed by final extension at 72°C for 10 minutes.
Slice preparation and electrophysiological recordings
Synaptic function and plasticity were assessed in acute
brain tissue slices, with the experimenter blinded to the
genotype under investigation. Adult male wildtype and
TG HA-cEPOR mice (three to four months old) were
decapitated under deep ether anesthesia, the brain was
rapidly removed from the skull and placed in chilled arti-
ficial cerebrospinal fluid (ACSF) for one to two minutes.
Acute neocortical/hippocampal tissue slices (400 μm
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Page 10 of 16thick transverse slices) were cut from the forebrain using
a vibroslicer (752M Vibroslice, Campden Instruments,
Loughborough, UK). The slices were then separated in
the sagittal midline, transferred to an Oslo style interface
recording chamber and left undisturbed for at least
90 minutes to ensure recovery from surgical trauma. The
recording chamber was kept at a temperature of 32 -
33°C, continuously aerated with 95% O2 -5 %C O 2
(400 ml/minute), and perfused with oxygenated ACSF
(3 - 4 ml/minute). The ACSF contained (in mM): 130
NaCl, 3.5 KCl, 1.25 NaH2PO4,2 4N a H C O 3,1 . 2C a C l 2,
1.2 MgSO4, and 10 dextrose; aerated with 95% O2 -5 %
CO2 to adjust pH to 7.4.
Orthodromically evoked field excitatory postsynaptic
potentials (fEPSPs) were elicited by stimulation of Schaffer
collaterals and recorded in stratum radiatum of the CA1
subfield with a locally constructed extracellular DC poten-
tial amplifier as described earlier [17,52]. Unipolar stimuli
of 0.1 ms duration, negative polarity and 10-150 μA ampli-
tude were generated by a stimulator (Grass S88 stimulator
equipped with PSIU6 stimulus isolation units, Grass
Instruments, Astro-Med Inc., Rodgau, Germany) and
delivered via stimulation electrodes made from steel
microwire (50 μm diameter, AM-Systems, Carlsborg WA,
USA; [53]). Extracellular recording electrodes were pulled
from thin-walled borosilicate glass capillaries (GC150TF-
10, Harvard Apparatus, Holliston MA, USA) using a hori-
zontal electrode puller (P-97 Flaming/Brown Micropipette
Puller, Sutter Instruments, Novato CA, USA). They were
filled with ACSF and their tips were trimmed to a final
resistance of approximately 5 MΩ. Evoked responses were
sampled at an acquisition rate of 20 kHz using an Axon
Instruments Digitizer 1322A and PClamp 9.2 software
(Molecular Devices Corporation, Sunnyvale CA, USA).
Synaptic function and neuronal excitability were assessed
by recording input-output curves (10-150 μAs t i m u l u s
intensity) and synaptic plasticity was tested by inducing
paired-pulse facilitation (PPF) and long-term potentiation
(LTP). For PPF and LTP recordings, stimulation intensity
was adjusted to obtain half-maximum response ampli-
tudes. In PPF recordings, the inter-stimulus interval was
varied in the range of 25 - 200 ms. LTP was induced by
three 1- second lasting 100 Hz trains, separated by 20 sec-
onds each, and fEPSPs were then recorded for 60 minutes.
To improve the signal to noise ratio of the recordings,
four consecutive sweeps were averaged online [53]; indivi-
dual stimuli were delivered every 5 seconds (input-output
curves and PPF) or 15 seconds (LTP). To quantify changes
in synaptic function and plasticity, the amplitude of the
EPSPs and their slope (within the 20% to 80% range of the
falling phase) were analyzed using PClamp 9.2 software
(Molecular Devices). To cancel out differences in absolute
fEPSPs slopes and amplitudes arising from electrode posi-
tions and the distance of recordings and stimulation
electrodes in individual slices, fEPSP amplitudes and
slopes (normalized to maximum amplitude/slope mea-
sured in a given slice) were analyzed.
Behavioral testing
All experiments were approved by the local Animal Care
and Use Committee in accordance with the German Ani-
mal Protection Law. For behavioral testing, mice were
housed in groups of three to five in standard plastic cages,
food and water ad libitum (except for the five-choice train-
ing period, see below). The temperature in the colony
room was maintained at 20 - 22°C, with a 12 hour light-
dark cycle (light on at 7:00 am). Behavioral experiments
were conducted by an investigator, blinded to the geno-
type, during the light phase of the day (between 8:00 am
and 17:00 pm). The order of testing was as follows: Ele-
vated plus maze, open field, hole board, rotarod, pre-pulse
inhibition, social interaction, Morris water maze, the five-
choice serial reaction time task and marble burying test.
The age of mice at the beginning of testing was 11 to
12 weeks. Inter-test interval was at least one to two days.
Elevated plus maze
In this test of anxiety, mice were placed in the central plat-
form, facing an open arm of the plus-maze (made of grey
plastic with a 5 × 5 cm central platform, 30 × 5 cm open
arms and 30 × 5 × 15 cm closed arms; illumination
120 lx). The behavior was recorded for five minutes by an
overhead video camera and a PC equipped with “Viewer
2” software (Biobserve GmbH, Bonn, Germany) to calcu-
late the time spent in open or closed arms, distance tra-
veled, number of arm visits, and velocity. The proportion
of time spent in open arms was used to estimate open arm
aversion (fear equivalent).
Open field
Spontaneous activity in the open field was tested in a grey
Perspex arena (120 cm in diameter, 25 cm high; illumina-
tion 120 lx). Mice were placed in the center and allowed
to explore the open field for seven minutes. The behavior
was recorded by a PC-linked overhead video camera.
“Viewer 2” software was used to calculate velocity, dis-
tance traveled, and time spent in central, intermediate or
peripheral zones of the open field.
Hole board
The hole board test measures exploratory activity. The
apparatus consisted of a 51 × 51 × 33 cm transparent Per-
spex chamber with a non-transparent floor, with 16 equally
spaced holes, 2 cm in diameter, 2 cm deep. Mice were
allowed to explore the chamber for five minutes and the
number of explored holes (head dips) was registered by a
computer software (TSE GmbH, Bad Homburg, Germany).
The illumination in the testing room was 120 lx.
Rotarod
The rotarod test examines motor function, balance, and
coordination. It comprised a rotating drum (Ugo Basile,
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40 rpm over five minutes. Mice were placed individually
on the drum and the latency of falling off the drum was
recorded using a stop-watch. To assess motor learning,
the rotarod test was repeated 24 hours later.
Pre-pulse inhibition test
In this test of sensorimotor gating, individual mice were
placed in small metal cages (90 × 40 × 40 mm) to restrict
major movements and exploratory behavior. The cages
were equipped with a movable platform floor attached to
a sensor that records vertical movements of the floor.
The cages were placed in four sound-attenuating isola-
tion cabinets (TSE GmbH, Bad Homburg, Germany).
Startle reflexes were evoked by acoustic stimuli delivered
from a loudspeaker that was suspended above the cage
and connected to an acoustic generator. The startle reac-
tion to an acoustic stimulus, which evokes a movement
of the platform and a transient force resulting from this
movement of the platform, was recorded with a compu-
ter during a recording window of 260 ms (beginning with
the onset of pre-pulse) and stored for further evaluation.
The recording window was defined from the onset of the
acoustic stimulus. An experimental session consisted of a
two minute habituation to 65 dB background white noise
(continuous throughout the session), followed by a base-
line recording for one minute at background noise. After
baseline recording, six pulse-alone trials using startle sti-
muli of 120 dB intensity and 40 ms duration were applied
in order to decrease influence of within-session habitua-
tion. These data were not included in the analysis of the
pre-pulse inhibition. For tests of pre-pulse inhibition, the
120 dB/40 ms startle pulse was applied either alone or
preceded by a pre-pulse stimulus of 70 db, 75 db, or
80 dB sound pressure level and 20 ms duration. An inter-
val of 100 ms with background white noise was employed
between each pre-pulse and pulse stimulus. The trials
were presented in a pseudorandom order with an interval
ranging from 8 to 22 seconds. The amplitude of the star-
tle response (expressed in arbitrary units) was defined as
the difference between the maximum force detected dur-
ing a recording window and the force measured immedi-
ately before the stimulus onset. Amplitudes were
averaged for each individual animal, separately for both
types of trials (that is stimulus alone or stimulus pre-
ceded by a pre-pulse). Pre-pulse inhibition was calculated
as the percentage of the startle response using the follow-
ing formula: %p r e - pulse inhibition = 100 - [(startle
amplitude after pre-pulse and pulse)/(startle amplitude
after pulse only) × 100].
Social interaction
Sociability and social memory were tested as described in
detail elsewhere (for example [54]). The social testing
arena was a rectangular, three-chambered box. Each
chamber was 20 × 40 × 22 cm in size. Dividing walls
were made from clear Plexiglas, with rectangular open-
ings (35 × 35 mm) allowing access into each chamber.
The chambers of the arena were cleaned, and fresh paper
chip bedding was added between trials. The test mouse
was first placed in the middle chamber and allowed to
explore for five minutes. The openings into the two-side
chambers were obstructed by plastic boxes during this
habituation phase. After the habituation period, an unfa-
miliar C57BL/6NCrl male mouse (stranger one) without
prior contact with the subject mouse was placed in one
of the side chambers. The location of stranger one in the
left versus right side chamber was systematically alter-
nated between trials. The stranger mouse was enclosed
in a small (60 × 60 × 100 mm), rectangular wire cage,
which allowed nose contact through the bars but pre-
vented fighting. The animals serving as strangers had
previously been habituated to placement in the small
cage. An identical empty wire cage was placed in the
opposite chamber. A heavy cup was placed on the top of
each of the small wire cages to prevent climbing by the
test mice. Both openings to the side chambers were then
unblocked, and the subject mouse was allowed to explore
the entire social test arena for a ten minute session. The
amount of time spent in each chamber and the number
of entries into each chamber were recorded by the video
tracking system “Viewer 2” (Biobserve GmbH). An entry
was defined as all four paws in one chamber. At the end
of the first ten minute trial, each mouse was tested in a
second ten minute session to quantify social preference
for a new stranger. A second, unfamiliar mouse (stranger
two) was placed into the previously empty wire cage. The
t e s tm o u s eh a dac h o i c eb e t w e e nt h ef i r s t ,a l r e a d y
explored mouse (familiar stranger one), and the novel
unfamiliar mouse (new stranger two). As described
above, measures were taken of the amount of time spent
in each chamber and the number of transitions between
chambers of the apparatus during the second ten minute
session. Based on the amount of time spent in each
chamber, a ‘sociability index’ and a ‘social memory index’
(with a value of 0 meaning no preference) were calculated
according to the following formulas:
Sociability index =( ( Timestranger/(Timestranger + Timeempty)) × 100) − 50.
Memory index =( ( Timenovel mouse/(Timenovel mouse + Timefamiliar mouse)) × 100) − 50.
Morris water maze
Spatial learning and memory was assessed in a water
maze [27]. A large circular tank (diameter 1.2 m, depth
0.4 m) was filled with opaque water (25 ± 1°C, depth 0.3
m) and the escape platform (10 × 10 cm) was sub-
merged 1 cm below the surface. The swim patterns
were monitored by a computer and the video-tracking
system “Viewer 2”. The escape latency, swim speed, path
length, and trajectory of swimming were recorded for
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trained to swim to a clearly visible platform (visible plat-
form task) that was marked with a 15 cm high black flag
and placed pseudo-randomly in different locations
across trials (non-spatial training). The extra-maze cues
were hidden during these trials. After two days of visible
platform training, hidden platform training (spatial
training) was performed. For eight days, mice were
trained to find a hidden platform (that is the flag was
removed) that was located in the center of one of the
four quadrants of the pool. The location of the platform
was fixed throughout testing. Mice had to navigate
using extra-maze cues that were placed on the walls of
the testing room. Every day, mice went through four
trials with an inter-trial interval of five minutes. The
mice were placed into the pool facing the side wall ran-
domly at one of four start locations and allowed to
swim until they found the platform, or for a maximum
of 90 seconds. Any mouse that failed to find the plat-
form within 90 seconds was guided to the platform. The
animal then remained on the platform for 20 seconds
before being removed from the pool. The next day after
completion of the hidden platform training, a probe trial
was conducted in order to determine whether mice used
a spatial strategy to find the platform or not. The plat-
f o r mw a sr e m o v e df r o mt h ep o o la n dt h em i c ew e r e
allowed to swim freely for 90 seconds. The percentage
of time spent in each quadrant of the pool as well as
the number of times the mice crossed the former posi-
tion of the hidden platform were recorded. In order to
investigate the flexibility of cognitive processes in mice,
the reversal water maze test was performed. The experi-
mental procedure was identical to the one used for the
hidden platform training with the exception that the
escape platform was moved from the original position
to the neighboring quadrant.
The 5-choice serial reaction time task (5-CSRTT)
The 5-choice serial reaction time task (5-CSRTT) mea-
sures higher brain functions, ranging from various dis-
crete learning/memory to attentional paradigms [55,56].
Mice were trained in an operant chamber (width 15.5
cm, depth 20 cm, height 18 cm; Med Associates Inc, St.
Albans, USA), enclosed in a sound attenuating box and
connected to a Fujitsu Siemens PC. One wall of the oper-
ant chamber had a curved shape and carried an array of
five stimulus holes. The stimulus holes were 1.2 cm in
diameter and contained a LED stimulus light (depth: 1
cm) in the rear. Infrared photocell pairs were located at 4
mm from the entrance of the stimulus holes and detected
nose pokes of mice into the holes. The wall opposite to
the stimulus holes contained a magazine cup, also with a
photocell detector of head entries, in which liquid reward
(4% sucrose solution) was delivered always
simultaneously with illumination of the magazine. The
house light was located 32 cm above the magazine.
Habituation and magazine training Two days before
starting training, mice were habituated to the liquid
reward of 4% sucrose solution in their home cages over
night. The day before starting magazine training, sucrose
bottles were removed and mice were water deprived.
Water deprivation was applied during the entire experi-
mental period. Immediately after finishing the daily test
sessions, mice were given water in individual cages for 20
minutes. Magazine training consisted of four consecutive
phases (M1 to M4), one phase per day, each lasting for
15 minutes, with all stimulus holes closed. In the first
phase (M1), liquid reward was delivered (10 μl) upon
initiation of the training session. In the second phase of
magazine training (M2), the number of potential rewards
was increased, with a fixed interval of 118 seconds
between reward presentations. A head entry into the
magazine was required to collect the reward. In the third
phase (M3), the fixed interval was replaced by a head
entry-dependent interval of 100 seconds to obtain reward.
In the last phase (M4), this interval was further reduced
to 50 seconds, ideally yielding a consistently increasing
number of head entries. Head entries into the magazine
together with reward consumption were taken as indica-
tors for associating the magazine with reward delivery.
Shaping phases (operant and discriminant learning)
During shaping, mice were trained to perform a nose
poke into an illuminated stimulus hole in order to obtain
reward. The shaping procedure consisted of two phases
(each extending over several days, dependent on indivi-
dual performance, and with a daily session duration of 30
minutes) where mice were taught to associate nose pok-
ing into an illuminated hole with reward (phase S1), and
then trained to discriminate between those nose pokes
that lead to reward (illuminated holes) and those that do
not (unlit holes) (phase S2). Throughout shaping all sti-
mulus holes were open. During S1, all stimulus lights
were on. Any nose poke in a stimulus hole was rewarded.
The inter-trial interval (time from pick-up of reward to
next stimulus hole illumination) was set to eight seconds.
During S2, presentation of lit and unlit holes was con-
ducted in a pseudorandom manner. Mice were only
rewarded upon nose poking into a lit stimulus hole. Per-
forming a nose poke in an unlit hole led to switch-off of
the house light for five seconds. Mice in S1 were moved
to the next training phase once they had reached 35 to
40 nose pokes each on three consecutive days. The num-
ber of trials in S2 was 60 per day and training in this
phase was terminated when mice had arrived at a stable
performance of ≥70% correct responses for three conse-
cutive days.
5-CSRTT training The training session started with
illumination of magazine light and presentation of 4%
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seconds after head entry, light (initially set to sixteen
seconds) was randomly presented in one of the five sti-
mulus holes. A correct response, that is nose poking
into the lit hole, led to reward (6 μl) and the next trial
start after eight seconds (inter-trial interval, ITI). Nose
poking in an unlit stimulus hole, that is an incorrect
response, led to extinguishing the house light for five
seconds (time-out) and no reward. Further nose pokes
during time-out extended that period for an additional
five seconds each. If a mouse did not respond by nose
poking into any of the holes during stimulus presenta-
tion, an omission was counted. As a consequence, no
reward was presented. Also omissions provoked time-
out. A training session was terminated after 30 minutes
or upon performing 60 trials, whichever came first.
Mice were trained in the phase with 16 second stimulus
duration until they reached clearly defined performance
criteria (≥75% accuracy [correct responses/correct +
incorrect responses * 100], ≤20% omissions and at least
50 trials performed over three consecutive days). Six
such phases followed with gradually declining stimulus
duration up to 1.4 seconds (16, 8, 4, 2, 1.8 and 1.4 sec-
onds). In the first phases, mice had time to respond as
long as the stimulus light was on. For phases with sti-
mulus duration below five seconds, the response time
(so called limited hold) was added up to five seconds.
Baseline training and attentional manipulations
After the acquisition phase, which was terminated by
reaching stable performance criteria in the 1.4 second-
phase (see above), mice were trained at ‘baseline para-
meters’, that is stimulus duration of 1.4 seconds, an ITI
of 8 seconds and a maximum of 60 trials. This training
was performance-independent, lasted for 21 days (one
session/day) and was conducted to further stabilize per-
formance of mice [57]. Immediately after baseline train-
ing, attentional intervention phases (INT1-5) succeeded
in the following manner: (INT1) variable, long ITI (8, 9,
10 and 11 second); (INT2) variable, short ITI (5, 6, 7
and 8 second); (INT3) variable, short stimulus duration
(1.4, 1.0, 0.6 and 0.2 seconds); (INT4) variable long ITI
(8, 9, 10 and 11 seconds) coupled with variable short sti-
mulus duration (1.4, 1.0, 0.6 and 0.2 seconds) and
(INT5) short stimulus duration (0.6 second) applied
simultaneously with a sound distracter (80 dB, white
noise). INT1, INT2, INT3 and INT5 lasted for four days
(one session/day), while INT4 was conducted for 15
days (one session/day). Between two intervention phases,
mice were kept in a ‘recovery’ phase, consisting of base-
line parameters, until they re-reached the above
described baseline performance criteria. This was done
to rule out the impact of motivational and learning fac-
tors resulting from the prior intervention phase [58].
Main task parameters analyzed in all experimental
conditions were the following: % of omissions (= pro-
portion of omitted trials), % of accuracy (= proportion
of correct responses), reward latency, reaction time and
number of premature responses. All these parameters,
except for the number of premature responses, were
assessed over all trial blocks (that is one trial block con-
tains ten trials, six trial blocks in total) and/or over the
corresponding inter-trial intervals, and/or the respective
stimulus durations, collapsed over the whole corre-
sponding test period. For premature responses, the aver-
age over the corresponding test period was calculated.
Marble burying test
The marble burying test is used to assess stereotypies
and obsessive-compulsive behaviors in mice [59]. Mice
were tested in plastic cages (34.5 × 56.5 × 18 cm) filled
with 5 cm deep wood chip bedding. Twenty-four glass
marbles evenly spaced (4 cm apart) were placed on the
surface. Individual mice were put in the cage and left
there for 30 minutes. Illumination was dimmed (6 lx).
The number of buried marbles (to 2/3 their depth) dur-
ing this time was counted.
Statistical analysis
Statistical analysis was performed using the statistical
programs SPSS for windows, release 16 (SPSS Inc., Chi-
cago, USA) and GraphPad Prism version 4.00 for Win-
dows, (GraphPad Software, San Diego, USA). We
applied 2-way ANOVA for repeated measures, chi
2-
Test, Mann-Whitney U-Test, Wilcoxon Test and survi-
val analysis where indicated. Bonferroni and Dunn’s
multiple comparison tests were used for post-hoc analy-
sis. Threshold for significance was P <0 . 0 5 .A l ld a t aa r e
presented as mean ± SEM (standard error of the mean).
Additional material
Additional file 1: Expression of HA-cEPOR in the ’TG2’ line.
Forebrain-specific expression of HA-cEPOR transgene also in line ’TG2’
was revealed by immunohistochemistry. A monoclonal antibody against
the HA-tag was used to stain coronal sections of hippocampus. HA-
cEPOR expression is absent in WT mice (A and B). Similar to the line
’TG1’, HA-cEPOR expression is restricted to the pyramidal neurons of
cortex (C), CA1 (D), CA3 subregions of hippocampus and granular layer
of dentate gyrus. Scale bars; 100 μm and 500 μm.
Additional file 2: Overexpression of cEPOR does not affect overall
brain morphology. (A) Coronal sections from WT and TG mice were
stained with haematoxylin-eosin and (B) Luxol Fast Blue. General brain
morphology and myelin architecture were comparable between WT and
TG mice. Scale bars; 1 mm.
Additional file 3: Within-day trial analysis in the hidden platform
paradigm of Morris water maze. In cEPOR TG mice, there is a
tendency of faster within-day learning, that is shorter latency to reach
the platform on days one and two. However, on most of the training
days, ANOVA did not reach significance levels. WT n = 18; TG n = 13;
mean ± SEM presented.
Additional file 4: Main parameters and results of the 5-choice serial
reaction time task (5-CSRTT) in WT and cEPOR TG mice.
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